ADIM
ENVX icon

Alpha DNA Investment Management’s Enovix ENVX Stock Holding History

Alpha DNA Investment Management’s Portfolio ENVX Stock Details ENVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-53,786
Closed -$512K – 66
2024
Q4 		$512K Buy
+53,786
New +$472K 0.19% 99

Other funds holding ENVX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ECP
Electron Capital Partners New York $2.55B AUM 87.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Alpha DNA Investment Management's ENVX Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of Enovix (ENVX) in Q1 2025, closing a stake of 53,786 shares — an estimated $512K sold.

Alpha DNA Investment Management first reported a position in ENVX in Q4 2024 and held it in 1 quarter. The position peaked at $512K in Q4 2024. 315 funds tracked by Wall St. Rank hold ENVX as of Q1 2025.

  • Alpha DNA Investment Management reported no remaining Enovix position as of Q1 2025 after selling out during the quarter.
  • Alpha DNA Investment Management sold 53,786 Enovix shares in Q1 2025, an estimated $512K.
  • Alpha DNA Investment Management first reported a position in Enovix in Q4 2024 and held it in 1 quarter.
  • Alpha DNA Investment Management's Enovix position peaked at $512K in Q4 2024.
  • 315 funds tracked by Wall St. Rank held Enovix as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.